基于新版《药品管理法》的实施对药品安全监管的研究 工商管理专业VIP专享VIP免费

基于新版《药品管理法》的实施对药品安全监管的研究摘要近些年，随着科学技术，医疗器械等不断的发展创新，人们生活水平的不断提高，对医疗健康问题日益关注，医患纠纷问题屡屡发生。其中药品安全问题成为社会广泛关注的热点话题，新版《药品管理法》在传统药物管理理念的基础上进一步创新，吸收国内外的先进药物管理理念，对我国药品监管提出了更大挑战。鉴于此，在本文中通过对新版《药品管理法》进行详细研究分析，探究其在药品安全监管工作中的变化，以及当前我国药品安全监管中存在的一系列问题，并提出相应的解决措施，促进我国药品安全监管工作的发展和创新。同时，通过对新版《药品管理法》监管领域的模式创新进行探讨，希望能够有利于我国药品市场健康有序的发展,药品消费者能够用上放心药。关键词：药品监管；风险管理；全程管控；社会共治IResearchondrugsafetysupervisionbasedontheimplementationofnewdrugadministrationlawAbstractDrugsafetyisrelatedtopeople'slivelihood.Inordertoensurethehealthydevelopmentofdrugmarketandthedailymedicationsafetyofthepeople,thenewversionofdrugadministrationlawhasabsorbedthematureconceptofpharmacovigilanceintheworldandthereformachievementsofdrugapprovalandreviewsysteminrecentyears,whichhasalsostrengthenedthedifficultyofdrugsupervisionandbroughtgreatchallenges.Thisdocumentaimstoanalyzethetypicalproblemsofnewchanges,putforwardfeasiblemeasuresandsuggestions,andpromotetheinnovationofdrugsupervision.Thispaperwilldiscussthemodeinnovationinthefieldofdrugsupervisionaftertherevisionofthedrugadministrationlawincombinationwiththethreeprinciplesofriskmanagement,wholeprocesscontrolandsocialcogovernance,hopingtobeconducivetothehealthyandorderlydevelopmentofChina'sdrugmarket,anddrugconsumerscanusesafedrugs.Keywords:drugsupervision;riskmanagement;wholeprocesscontrol;socialcogovernanceII目录第一章绪论......................................................................................................................11.1研究背景.....................................................................................................................11.2研究意义.....................................................................................................................1第二章新版《药品管理法》在监管方面的变化.................................................................22.1风险管理原则.............................................................................................................22.1.1药品研制和注册..............................................................................................22.1.2药品上市许可持有人......................................................................................22.1.3药品生产与经营..............................................................................................22.1.4药品上市后管理..............................................................................................32.2全程管控原则.............................................................................................................32.3社会共治原则.............................................................................................................42.3.1行业自律..........................................................................................................52.3.2公众参与..........................................................................................................52.3.3媒体监督..................................................................................